PHARMACEUTICAL COMPOSITION FOR TREATING OR AMELIORATING TOXICITIES OR SIDE EFFECTS INDUCED BY MOLECULAR TARGETED THERAPY

摘要

According to the present invention there is provided a method for treating or ameliorating toxicity or side effects caused by molecular targeting therapy from blocking cell growth and survival signaling pathways. The method comprises administering to a subject in need thereof a therapeutically effective amount of a histone deacetylase inhibitor and a pharmaceutically acceptable salt or solvate thereof.